Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Harpoon Therapeutics stock

Learn how to easily invest in Harpoon Therapeutics stock.

Harpoon Therapeutics is a biotechnology business based in the US. Harpoon Therapeutics shares (HARP) are listed on the NASDAQ and all prices are listed in US Dollars. Harpoon Therapeutics employs 46 staff and has a trailing 12-month revenue of around $46.5 million.

How to buy Harpoon Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – HARP. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Harpoon Therapeutics stock price (NASDAQ: HARP)

Use our graph to track the performance of HARP stocks over time.

Harpoon Therapeutics shares at a glance

Information last updated 2023-09-24.
Latest market close$4.08
52-week range$3.86 - $14.50
50-day moving average $0.80
200-day moving average $0.78
Wall St. target price$53.33
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-9.95

Buy Harpoon Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Harpoon Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Harpoon Therapeutics price performance over time

Historical closes compared with the close of $4.08 from 2023-09-27

1 week (2023-09-21) 3.03%
1 month (2023-08-28) 334.50%
3 months (2023-06-28) 522.90%
6 months (2023-03-28) 508.96%
1 year (2022-09-28) 338.71%
2 years (2021-09-28) -50.49%
3 years (2020-09-28) 16
5 years (2018-09-24) N/A

Harpoon Therapeutics financials

Revenue TTM $46.5 million
Gross profit TTM $-49,478,000
Return on assets TTM -26.97%
Return on equity TTM -272.17%
Profit margin -86.72%
Book value $0.08
Market Capitalization $346.5 million

TTM: trailing 12 months

Harpoon Therapeutics share dividends

We're not expecting Harpoon Therapeutics to pay a dividend over the next 12 months.

Have Harpoon Therapeutics's shares ever split?

Harpoon Therapeutics's shares were split on a 1:10 basis on 4 September 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Harpoon Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Harpoon Therapeutics shares which in turn could have impacted Harpoon Therapeutics's share price.

Harpoon Therapeutics share price volatility

Over the last 12 months, Harpoon Therapeutics's shares have ranged in value from as little as $3.86 up to $14.5. A popular way to gauge a stock's volatility is its "beta".

HARP.US volatility(beta: 1.55)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Harpoon Therapeutics's is 1.5478. This would suggest that Harpoon Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Harpoon Therapeutics overview

Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; and HPN217 that is in Phase I clinical trials for the treatment of multiple myeloma. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. It has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. The company was incorporated in 2015 and is headquartered in South San Francisco, California.

Frequently asked questions

What percentage of Harpoon Therapeutics is owned by insiders or institutions?
Currently 9.538% of Harpoon Therapeutics shares are held by insiders and 52.224% by institutions.
How many people work for Harpoon Therapeutics?
Latest data suggests 46 work at Harpoon Therapeutics.
When does the fiscal year end for Harpoon Therapeutics?
Harpoon Therapeutics's fiscal year ends in December.
Where is Harpoon Therapeutics based?
Harpoon Therapeutics's address is: 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is Harpoon Therapeutics's ISIN number?
Harpoon Therapeutics's international securities identification number is: US41358P1066
What is Harpoon Therapeutics's CUSIP number?
Harpoon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 41358P106

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site